Av. Vereador José Diniz 2270, CEP: 04604-003- Brooklin - São Paulo - SP - Brasil. Tel. +55 (11) 5090-5080/ (11) 9 8437-9824

Home
The Group
Services
Legistation
Contact

Display #

Anvisa aprova uso emergencial do medicamento molnupiravir para Covid-19.

Written by Latini Group on 05 May 2022.

The Group
Latini
Medstar
Latin Health
Technical Staff
Partners
Mission, Vision and Values

Services
Certification
Consulting
Due Diligence
INMETRO/Ministry of labour
Health Licensing
Registration
Regularização
Controlled Substances

Copyright © 2022 - Latini Group - Especialistas em Assuntos Regulatórios. Todos os direitos reservados.

Powered by Warp Theme Framework